FARMINGDALE, N.Y., July 7, 2015 /PRNewswire/ — Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, laparoscopic surgery and other surgical applications, announced its attendance at the 22nd International Meeting on Advanced Spine Techniques (“IMAST”) in Kuala Lumpur, Malaysia, from July 8-11, 2015. Misonix will be exhibiting and hosting a hands-on ultrasonic surgery workshop at IMAST this year.
The IMAST meeting is a three-day international forum with leading spine surgeons discussing, debating and demonstrating innovative surgical technologies that help improve patient care. The course includes the latest research on new and advanced techniques in treating scoliosis, trauma, tumors and degenerative diseases. The meeting is organized by the Scoliosis Research Society (“SRS”). The SRS membership includes more than 1,000 of the world’s leading spine surgeons, researchers, physician assistants, etc., who are involved in the research and treatment of spinal pathologies. Last year’s international meeting was attended by 776 delegates.
Misonix will showcase its ultrasonic BoneScalpel, which is rapidly gaining adoption by leading spine surgeons around the globe. The BoneScalpel provides unique benefits over traditional bone cutting tools as it offers clean, controlled bone incision and removal, while sparing elastic soft tissue structures such as the dura, nerves and arteries. The BoneScalpel has been reported to provide greater safety, reduced blood loss and blood transfusions, cell saver use, and decreased operative time in a variety of spine surgery procedures.
Dr. Peter Newton from Rady Children’s Hospital in San Diego, CA will moderate the hands-on workshop, which will review clinical experiences and surgical benefits of the BoneScalpel over traditional technologies. The workshop will demonstrate these benefits along with surgical techniques and tips in a variety of spinal procedures, including deformity correction and minimally-invasive fusions. The presenting faculty includes Dr. Newton, Dr. Juan Uribe from the University of South Florida, Tampa, FL and Dr. Greg Mundis from Scripps Memorial Hospital, La Jolla, CA. Surgeon attendees will have the opportunity to trial the BoneScalpel on bone models and engage in detailed discussions with the faculty.
Dr. Peter Newton elaborated on his personal experience, “In my surgical experience, the BoneScalpel is safer than traditional methods for cutting bone in spine procedures. It also has allowed me to perform surgeries very efficiently with reduced blood loss and time savings.” Dr. Mundis, of the presenting faculty, agreed, “The BoneScalpel offers greater clinical and economic efficiencies in my surgical practice.”
Michael A. McManus, Jr., President and Chief Executive Officer of Misonix, commented, “We are enthusiastic about BoneScalpel’s unique benefits and increasing utilization in advanced spine surgeries. IMAST is a renowned spine meeting and an important podium to showcase the BoneScalpel. We are also very excited to have another opportunity to host a BoneScalpel hands-on workshop presented by a talented team of surgical experts. We thank this distinguished group of surgeons for their participation and support. Last year’s IMAST workshop created significant interest in the BoneScalpel, and we have no doubt this year will be even more successful.”
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix’s therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix’s proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company’s Web site at www.misonix.com.